These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27638599)

  • 1. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
    Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
    J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice.
    Rafi MA; Rao HZ; Luzi P; Wenger DA
    Mol Ther; 2015 Nov; 23(11):1681-1690. PubMed ID: 26329589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
    Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
    Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features.
    Rafi MA; Rao HZ; Luzi P; Luddi A; Curtis MT; Wenger DA
    Mol Genet Metab; 2015 Mar; 114(3):459-66. PubMed ID: 25533112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy.
    Reddy AS; Kim JH; Hawkins-Salsbury JA; Macauley SL; Tracy ET; Vogler CA; Han X; Song SK; Wozniak DF; Fowler SC; Klein RS; Sands MS
    J Neurosci; 2011 Jul; 31(27):9945-57. PubMed ID: 21734286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice.
    Pan X; Sands SA; Yue Y; Zhang K; LeVine SM; Duan D
    Hum Gene Ther; 2019 Sep; 30(9):1039-1051. PubMed ID: 31184217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease.
    Rafi MA; Rao HZ; Luzi P; Curtis MT; Wenger DA
    Mol Ther; 2012 Nov; 20(11):2031-42. PubMed ID: 22850681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.
    Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS
    Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain.
    Dolcetta D; Perani L; Givogri MI; Galbiati F; Amadio S; Del Carro U; Finocchiaro G; Fanzani A; Marchesini S; Naldini L; Roncarolo MG; Bongarzone E
    J Gene Med; 2006 Aug; 8(8):962-71. PubMed ID: 16732552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy.
    Qin EY; Hawkins-Salsbury JA; Jiang X; Reddy AS; Farber NB; Ory DS; Sands MS
    Mol Genet Metab; 2012 Sep; 107(1-2):186-96. PubMed ID: 22704480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.
    Heller GJ; Marshall MS; Issa Y; Marshall JN; Nguyen D; Rue E; Pathmasiri KC; Domowicz MS; van Breemen RB; Tai LM; Cologna SM; Crocker SJ; Givogri MI; Sands MS; Bongarzone ER
    Mol Ther; 2021 May; 29(5):1883-1902. PubMed ID: 33508430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease.
    Galbiati F; Givogri MI; Cantuti L; Rosas AL; Cao H; van Breemen R; Bongarzone ER
    J Neurosci Res; 2009 Jun; 87(8):1748-59. PubMed ID: 19185028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
    Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
    Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
    Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
    Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.
    Li Y; Miller CA; Shea LK; Jiang X; Guzman MA; Chandler RJ; Ramakrishnan SM; Smith SN; Venditti CP; Vogler CA; Ory DS; Ley TJ; Sands MS
    Mol Ther; 2021 Feb; 29(2):691-701. PubMed ID: 33388420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease).
    Bradbury AM; Rafi MA; Bagel JH; Brisson BK; Marshall MS; Pesayco Salvador J; Jiang X; Swain GP; Prociuk ML; ODonnell PA; Fitzgerald C; Ory DS; Bongarzone ER; Shelton GD; Wenger DA; Vite CH
    Hum Gene Ther; 2018 Jul; 29(7):785-801. PubMed ID: 29316812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy.
    Lin D; Donsante A; Macauley S; Levy B; Vogler C; Sands MS
    Mol Ther; 2007 Jan; 15(1):44-52. PubMed ID: 17164774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo.
    Meng XL; Shen JS; Watabe K; Ohashi T; Eto Y
    Mol Genet Metab; 2005 Apr; 84(4):332-43. PubMed ID: 15781194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.